[Total androgen blockade].
Namiki
Mikio
M
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science.
Mizokami
Atsushi
A
D000726:Androgen Antagonists / Q000627:therapeutic use*; D000813:Anilides / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002369:Castration; D002715:Chlormadinone Acetate / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005485:Flutamide / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use; D008297:Male; D009570:Nitriles; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D014105:Tosyl Compounds
D000726:Androgen Antagonists; D000813:Anilides; D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D014105:Tosyl Compounds; D017273:Goserelin; D002715:Chlormadinone Acetate; D007987:Gonadotropin-Releasing Hormone; D005485:Flutamide; C053541:bicalutamide; D016729:Leuprolide